Jump to navigation
Venture capitalists have been shying away from early-stage drug funding. So some nonprofit foundations are filling the gap in a practice known as venture philanthropy. Janet Babin reports.
<iframe src="http://www.marketplace.org/node/22273/player/storyplayer" frameborder="0" scrolling="no" width="100%" height="240px"></iframe>